This trial will test whether a blood test for HPV DNA can help doctors better diagnose HPV-positive oropharynx cancer.
- Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
1 Primary · 3 Secondary · Reporting Duration: Long-term follow-up for up to 2 years
Awards & Highlights
0 Treatment Group
40 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
To what extent has the scope of this clinical trial been expanded?
"Affirmative. The clinicaltrials.gov website indicates that this investigation is currently recruiting members, starting from the date of its inception on March 24th 2021 and recently updated on June 8th 2022. 40 volunteers are required across a single site for successful completion of the research project." - Anonymous Online Contributor
Is this clinical trial still recruiting participants?
"Clinicaltrials.gov states that this clinical trial is still in the recruitment phase, having been initially posted on March 24th 2021 and recently updated on June 8th 2022." - Anonymous Online Contributor